This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Dr. Viktor Lemgart, PhD
Senior Scientist, In Vivo Immune Cell Reprogramming at Sanofi
Speaker

Profile

With an engineering background from the Technical University of Denmark, Viktor is focused on designing and testing novel mRNA-LNPs that can be used in Sanofi’s LNP-mRNA platform to target various immune cells directly in vivo.

Agenda Sessions

  • In vivo Reprogramming of Immune Cells Using Targeted LNPs

    11:15am